Global Small Molecule Targeted Cancer Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 117949
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Small Molecule Targeted Cancer Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Small Molecule Targeted Cancer Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Lymphoma accounting for % of the Small Molecule Targeted Cancer Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Small Molecule Targeted Cancer Therapy include OncoGenex Pharmaceuticals, Inc., Cytokinetics Inc., Hospira Inc., GlaxoSmithKline plc, and Boehringer Ingelheim GmbH, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Small Molecule Targeted Cancer Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Monoclonal Antibodies

Small Molecules

Small Molecule Drug Conjugates

Market segment by Application, can be divided into

Lymphoma

Melanoma

Multiple Myeloma

Breast Cancer

Prostate Cancer

Other Cancers

Market segment by players, this report covers

OncoGenex Pharmaceuticals, Inc.

Cytokinetics Inc.

Hospira Inc.

GlaxoSmithKline plc

Boehringer Ingelheim GmbH

Bayer HealthCare AG

Abbott Laboratories

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Small Molecule Targeted Cancer Therapy product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Small Molecule Targeted Cancer Therapy, with revenue, gross margin and global market share of Small Molecule Targeted Cancer Therapy from 2019 to 2022.

Chapter 3, the Small Molecule Targeted Cancer Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Small Molecule Targeted Cancer Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Small Molecule Targeted Cancer Therapy research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Small Molecule Targeted Cancer Therapy

1.2 Classification of Small Molecule Targeted Cancer Therapy by Type

1.2.1 Overview: Global Small Molecule Targeted Cancer Therapy Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type in 2021

1.2.3 Monoclonal Antibodies

1.2.4 Small Molecules

1.2.5 Small Molecule Drug Conjugates

1.3 Global Small Molecule Targeted Cancer Therapy Market by Application

1.3.1 Overview: Global Small Molecule Targeted Cancer Therapy Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Lymphoma

1.3.3 Melanoma

1.3.4 Multiple Myeloma

1.3.5 Breast Cancer

1.3.6 Prostate Cancer

1.3.7 Other Cancers

1.4 Global Small Molecule Targeted Cancer Therapy Market Size & Forecast

1.5 Global Small Molecule Targeted Cancer Therapy Market Size and Forecast by Region

1.5.1 Global Small Molecule Targeted Cancer Therapy Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Small Molecule Targeted Cancer Therapy Market Size by Region, (2017-2022)

1.5.3 North America Small Molecule Targeted Cancer Therapy Market Size and Prospect (2017-2028)

1.5.4 Europe Small Molecule Targeted Cancer Therapy Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size and Prospect (2017-2028)

1.5.6 South America Small Molecule Targeted Cancer Therapy Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Small Molecule Targeted Cancer Therapy Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Small Molecule Targeted Cancer Therapy Market Drivers

1.6.2 Small Molecule Targeted Cancer Therapy Market Restraints

1.6.3 Small Molecule Targeted Cancer Therapy Trends Analysis

2 Company Profiles

2.1 OncoGenex Pharmaceuticals, Inc.

2.1.1 OncoGenex Pharmaceuticals, Inc. Details

2.1.2 OncoGenex Pharmaceuticals, Inc. Major Business

2.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Product and Solutions

2.1.4 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 OncoGenex Pharmaceuticals, Inc. Recent Developments and Future Plans

2.2 Cytokinetics Inc.

2.2.1 Cytokinetics Inc. Details

2.2.2 Cytokinetics Inc. Major Business

2.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Product and Solutions

2.2.4 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Cytokinetics Inc. Recent Developments and Future Plans

2.3 Hospira Inc.

2.3.1 Hospira Inc. Details

2.3.2 Hospira Inc. Major Business

2.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Product and Solutions

2.3.4 Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Hospira Inc. Recent Developments and Future Plans

2.4 GlaxoSmithKline plc

2.4.1 GlaxoSmithKline plc Details

2.4.2 GlaxoSmithKline plc Major Business

2.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Product and Solutions

2.4.4 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 GlaxoSmithKline plc Recent Developments and Future Plans

2.5 Boehringer Ingelheim GmbH

2.5.1 Boehringer Ingelheim GmbH Details

2.5.2 Boehringer Ingelheim GmbH Major Business

2.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Product and Solutions

2.5.4 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans

2.6 Bayer HealthCare AG

2.6.1 Bayer HealthCare AG Details

2.6.2 Bayer HealthCare AG Major Business

2.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Product and Solutions

2.6.4 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Bayer HealthCare AG Recent Developments and Future Plans

2.7 Abbott Laboratories

2.7.1 Abbott Laboratories Details

2.7.2 Abbott Laboratories Major Business

2.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Product and Solutions

2.7.4 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Abbott Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Small Molecule Targeted Cancer Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Small Molecule Targeted Cancer Therapy Players Market Share in 2021

3.2.2 Top 10 Small Molecule Targeted Cancer Therapy Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Small Molecule Targeted Cancer Therapy Players Head Office, Products and Services Provided

3.4 Small Molecule Targeted Cancer Therapy Mergers & Acquisitions

3.5 Small Molecule Targeted Cancer Therapy New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Small Molecule Targeted Cancer Therapy Revenue and Market Share by Type (2017-2022)

4.2 Global Small Molecule Targeted Cancer Therapy Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2017-2022)

5.2 Global Small Molecule Targeted Cancer Therapy Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Small Molecule Targeted Cancer Therapy Revenue by Type (2017-2028)

6.2 North America Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2028)

6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Country

6.3.1 North America Small Molecule Targeted Cancer Therapy Revenue by Country (2017-2028)

6.3.2 United States Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

6.3.3 Canada Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

6.3.4 Mexico Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Small Molecule Targeted Cancer Therapy Revenue by Type (2017-2028)

7.2 Europe Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2028)

7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Country

7.3.1 Europe Small Molecule Targeted Cancer Therapy Revenue by Country (2017-2028)

7.3.2 Germany Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

7.3.3 France Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

7.3.5 Russia Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

7.3.6 Italy Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Type (2017-2028)

8.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2028)

8.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region

8.3.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Region (2017-2028)

8.3.2 China Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

8.3.3 Japan Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

8.3.4 South Korea Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

8.3.5 India Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

8.3.7 Australia Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Small Molecule Targeted Cancer Therapy Revenue by Type (2017-2028)

9.2 South America Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2028)

9.3 South America Small Molecule Targeted Cancer Therapy Market Size by Country

9.3.1 South America Small Molecule Targeted Cancer Therapy Revenue by Country (2017-2028)

9.3.2 Brazil Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

9.3.3 Argentina Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue by Type (2017-2028)

10.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2028)

10.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country

10.3.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue by Country (2017-2028)

10.3.2 Turkey Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

10.3.4 UAE Small Molecule Targeted Cancer Therapy Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Small Molecule Targeted Cancer Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Small Molecule Targeted Cancer Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Small Molecule Targeted Cancer Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Small Molecule Targeted Cancer Therapy Revenue (USD Million) by Region (2017-2022)

Table 5. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Region (2023-2028)

Table 6. OncoGenex Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 7. OncoGenex Pharmaceuticals, Inc. Major Business

Table 8. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Product and Solutions

Table 9. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Cytokinetics Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Cytokinetics Inc. Major Business

Table 12. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Product and Solutions

Table 13. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Hospira Inc. Corporate Information, Head Office, and Major Competitors

Table 15. Hospira Inc. Major Business

Table 16. Hospira Inc. Small Molecule Targeted Cancer Therapy Product and Solutions

Table 17. Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors

Table 19. GlaxoSmithKline plc Major Business

Table 20. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Product and Solutions

Table 21. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors

Table 23. Boehringer Ingelheim GmbH Major Business

Table 24. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Product and Solutions

Table 25. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Bayer HealthCare AG Corporate Information, Head Office, and Major Competitors

Table 27. Bayer HealthCare AG Major Business

Table 28. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Product and Solutions

Table 29. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 31. Abbott Laboratories Major Business

Table 32. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product and Solutions

Table 33. Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Global Small Molecule Targeted Cancer Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 35. Global Small Molecule Targeted Cancer Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 36. Breakdown of Small Molecule Targeted Cancer Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 37. Small Molecule Targeted Cancer Therapy Players Head Office, Products and Services Provided

Table 38. Small Molecule Targeted Cancer Therapy Mergers & Acquisitions in the Past Five Years

Table 39. Small Molecule Targeted Cancer Therapy New Entrants and Expansion Plans

Table 40. Global Small Molecule Targeted Cancer Therapy Revenue (USD Million) by Type (2017-2022)

Table 41. Global Small Molecule Targeted Cancer Therapy Revenue Share by Type (2017-2022)

Table 42. Global Small Molecule Targeted Cancer Therapy Revenue Forecast by Type (2023-2028)

Table 43. Global Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2022)

Table 44. Global Small Molecule Targeted Cancer Therapy Revenue Forecast by Application (2023-2028)

Table 45. North America Small Molecule Targeted Cancer Therapy Revenue by Type (2017-2022) & (USD Million)

Table 46. North America Small Molecule Targeted Cancer Therapy Revenue by Type (2023-2028) & (USD Million)

Table 47. North America Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2022) & (USD Million)

Table 48. North America Small Molecule Targeted Cancer Therapy Revenue by Application (2023-2028) & (USD Million)

Table 49. North America Small Molecule Targeted Cancer Therapy Revenue by Country (2017-2022) & (USD Million)

Table 50. North America Small Molecule Targeted Cancer Therapy Revenue by Country (2023-2028) & (USD Million)

Table 51. Europe Small Molecule Targeted Cancer Therapy Revenue by Type (2017-2022) & (USD Million)

Table 52. Europe Small Molecule Targeted Cancer Therapy Revenue by Type (2023-2028) & (USD Million)

Table 53. Europe Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2022) & (USD Million)

Table 54. Europe Small Molecule Targeted Cancer Therapy Revenue by Application (2023-2028) & (USD Million)

Table 55. Europe Small Molecule Targeted Cancer Therapy Revenue by Country (2017-2022) & (USD Million)

Table 56. Europe Small Molecule Targeted Cancer Therapy Revenue by Country (2023-2028) & (USD Million)

Table 57. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Type (2017-2022) & (USD Million)

Table 58. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Type (2023-2028) & (USD Million)

Table 59. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2022) & (USD Million)

Table 60. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Application (2023-2028) & (USD Million)

Table 61. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Region (2017-2022) & (USD Million)

Table 62. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Region (2023-2028) & (USD Million)

Table 63. South America Small Molecule Targeted Cancer Therapy Revenue by Type (2017-2022) & (USD Million)

Table 64. South America Small Molecule Targeted Cancer Therapy Revenue by Type (2023-2028) & (USD Million)

Table 65. South America Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2022) & (USD Million)

Table 66. South America Small Molecule Targeted Cancer Therapy Revenue by Application (2023-2028) & (USD Million)

Table 67. South America Small Molecule Targeted Cancer Therapy Revenue by Country (2017-2022) & (USD Million)

Table 68. South America Small Molecule Targeted Cancer Therapy Revenue by Country (2023-2028) & (USD Million)

Table 69. Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue by Type (2017-2022) & (USD Million)

Table 70. Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue by Type (2023-2028) & (USD Million)

Table 71. Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue by Application (2017-2022) & (USD Million)

Table 72. Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue by Application (2023-2028) & (USD Million)

Table 73. Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue by Country (2017-2022) & (USD Million)

Table 74. Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Small Molecule Targeted Cancer Therapy Picture

Figure 2. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type in 2021

Figure 3. Monoclonal Antibodies

Figure 4. Small Molecules

Figure 5. Small Molecule Drug Conjugates

Figure 6. Small Molecule Targeted Cancer Therapy Revenue Market Share by Application in 2021

Figure 7. Lymphoma Picture

Figure 8. Melanoma Picture

Figure 9. Multiple Myeloma Picture

Figure 10. Breast Cancer Picture

Figure 11. Prostate Cancer Picture

Figure 12. Other Cancers Picture

Figure 13. Global Small Molecule Targeted Cancer Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 14. Global Small Molecule Targeted Cancer Therapy Revenue and Forecast (2017-2028) & (USD Million)

Figure 15. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Region (2017-2028)

Figure 16. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Region in 2021

Figure 17. North America Small Molecule Targeted Cancer Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Europe Small Molecule Targeted Cancer Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. South America Small Molecule Targeted Cancer Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Small Molecule Targeted Cancer Therapy Market Drivers

Figure 23. Small Molecule Targeted Cancer Therapy Market Restraints

Figure 24. Small Molecule Targeted Cancer Therapy Market Trends

Figure 25. OncoGenex Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 26. Cytokinetics Inc. Recent Developments and Future Plans

Figure 27. Hospira Inc. Recent Developments and Future Plans

Figure 28. GlaxoSmithKline plc Recent Developments and Future Plans

Figure 29. Boehringer Ingelheim GmbH Recent Developments and Future Plans

Figure 30. Bayer HealthCare AG Recent Developments and Future Plans

Figure 31. Abbott Laboratories Recent Developments and Future Plans

Figure 32. Global Small Molecule Targeted Cancer Therapy Revenue Share by Players in 2021

Figure 33. Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 34. Global Top 3 Players Small Molecule Targeted Cancer Therapy Revenue Market Share in 2021

Figure 35. Global Top 10 Players Small Molecule Targeted Cancer Therapy Revenue Market Share in 2021

Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 37. Global Small Molecule Targeted Cancer Therapy Revenue Share by Type in 2021

Figure 38. Global Small Molecule Targeted Cancer Therapy Market Share Forecast by Type (2023-2028)

Figure 39. Global Small Molecule Targeted Cancer Therapy Revenue Share by Application in 2021

Figure 40. Global Small Molecule Targeted Cancer Therapy Market Share Forecast by Application (2023-2028)

Figure 41. North America Small Molecule Targeted Cancer Therapy Sales Market Share by Type (2017-2028)

Figure 42. North America Small Molecule Targeted Cancer Therapy Sales Market Share by Application (2017-2028)

Figure 43. North America Small Molecule Targeted Cancer Therapy Revenue Market Share by Country (2017-2028)

Figure 44. United States Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Canada Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Mexico Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Europe Small Molecule Targeted Cancer Therapy Sales Market Share by Type (2017-2028)

Figure 48. Europe Small Molecule Targeted Cancer Therapy Sales Market Share by Application (2017-2028)

Figure 49. Europe Small Molecule Targeted Cancer Therapy Revenue Market Share by Country (2017-2028)

Figure 50. Germany Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. France Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. United Kingdom Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Russia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Italy Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Asia-Pacific Small Molecule Targeted Cancer Therapy Sales Market Share by Type (2017-2028)

Figure 56. Asia-Pacific Small Molecule Targeted Cancer Therapy Sales Market Share by Application (2017-2028)

Figure 57. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Share by Region (2017-2028)

Figure 58. China Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Japan Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. South Korea Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. India Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Southeast Asia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Australia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South America Small Molecule Targeted Cancer Therapy Sales Market Share by Type (2017-2028)

Figure 65. South America Small Molecule Targeted Cancer Therapy Sales Market Share by Application (2017-2028)

Figure 66. South America Small Molecule Targeted Cancer Therapy Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East and Africa Small Molecule Targeted Cancer Therapy Sales Market Share by Type (2017-2028)

Figure 70. Middle East and Africa Small Molecule Targeted Cancer Therapy Sales Market Share by Application (2017-2028)

Figure 71. Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Share by Country (2017-2028)

Figure 72. Turkey Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Saudi Arabia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. UAE Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Methodology

Figure 76. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz